Healthcare provider profile · identity verified

Chi Ming Chan, PHARMD

Pharmacist · BONNEY LAKE, WA · NPI 1487101994

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1278	194
Levothyroxine Sodium	Levothyroxine Sodium	725	96
Gabapentin	Gabapentin	511	89
Amlodipine Besylate	Amlodipine Besylate	483	80
Lisinopril	Lisinopril	437	73
Losartan Potassium	Losartan Potassium	432	66
Tamsulosin Hcl	Tamsulosin Hcl	422	66
Trazodone Hcl	Trazodone Hcl	399	69
Quetiapine Fumarate	Quetiapine Fumarate	387	60
Duloxetine Hcl	Duloxetine Hcl	366	54
Omeprazole	Omeprazole	342	56
Furosemide	Furosemide	336	54
Metoprolol Succinate	Metoprolol Succinate	334	56
Mirtazapine	Mirtazapine	328	49
Famotidine	Famotidine	285	47
Eliquis	Apixaban	284	52
Sertraline Hcl	Sertraline Hcl	243	35
Metformin Hcl	Metformin Hcl	224	36
Pantoprazole Sodium	Pantoprazole Sodium	223	38
Rosuvastatin Calcium	Rosuvastatin Calcium	216	36
Risperidone	Risperidone	196	27
Memantine Hcl	Memantine Hcl	190	33
Citalopram Hbr	Citalopram Hydrobromide	174	32
Donepezil Hcl	Donepezil Hcl	172	28
Finasteride	Finasteride	170	24
Levetiracetam	Levetiracetam	160	19
Allopurinol	Allopurinol	157	23
Potassium Chloride	Potassium Chloride	149	22
Alendronate Sodium	Alendronate Sodium	144	22
Carvedilol	Carvedilol	140	24
Divalproex Sodium	Divalproex Sodium	135	16
Metformin Hcl Er	Metformin Hcl	135	25
Clopidogrel	Clopidogrel Bisulfate	131	22
Fluoxetine Hcl	Fluoxetine Hcl	128	21
Metoprolol Tartrate	Metoprolol Tartrate	120	20
Pravastatin Sodium	Pravastatin Sodium	120	18
Venlafaxine Hcl Er	Venlafaxine Hcl	119	13
Lamotrigine	Lamotrigine	113	17
Olanzapine	Olanzapine	109	21
Bupropion Xl	Bupropion Hcl	101	14
Jardiance	Empagliflozin	96	16
Escitalopram Oxalate	Escitalopram Oxalate	95	14
Fluticasone Propionate	Fluticasone Propionate	86	26
Spironolactone	Spironolactone	86	15
Baclofen	Baclofen	85	13
Simvastatin	Simvastatin	80	13
Hydralazine Hcl	Hydralazine Hcl	76	suppressed
Glipizide	Glipizide	74	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	70	12
Aripiprazole	Aripiprazole	69	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	66	13
Xarelto	Rivaroxaban	64	suppressed
Montelukast Sodium	Montelukast Sodium	60	11
Albuterol Sulfate Hfa	Albuterol Sulfate	58	22
Mirabegron Er	Mirabegron	52	11
Latanoprost	Latanoprost	51	suppressed
Propranolol Hcl	Propranolol Hcl	50	suppressed
Buspirone Hcl	Buspirone Hcl	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Anastrozole	Anastrozole	44	suppressed
Spiriva Handihaler	Tiotropium Bromide	44	suppressed
Chlorthalidone	Chlorthalidone	43	suppressed
Lovastatin	Lovastatin	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	suppressed
Ezetimibe	Ezetimibe	40	suppressed
Atenolol	Atenolol	38	suppressed
Divalproex Sodium Er	Divalproex Sodium	38	suppressed
Prazosin Hcl	Prazosin Hcl	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Calcitriol	Calcitriol	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Prednisone	Prednisone	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	31	suppressed
Gemtesa	Vibegron	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Zonisamide	Zonisamide	27	suppressed
Azithromycin	Azithromycin	26	suppressed
Icosapent Ethyl	Icosapent Ethyl	26	suppressed
Myrbetriq	Mirabegron	25	suppressed
Olanzapine Odt	Olanzapine	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Dapagliflozin	Dapagliflozin Propanediol	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Lithium Carbonate	Lithium Carbonate	24	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Ramelteon	Ramelteon	23	suppressed
Rivastigmine	Rivastigmine Tartrate	23	suppressed
Topiramate	Topiramate	23	suppressed
Torsemide	Torsemide	22	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Naltrexone Hcl	Naltrexone Hcl	20	suppressed
Oxcarbazepine	Oxcarbazepine	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Cartia Xt	Diltiazem Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Mycophenolic Acid	Mycophenolate Sodium	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Digoxin	Digoxin	18	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Valsartan	Valsartan	18	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Phenytoin	Phenytoin	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Sure Comfort	Pen Needle, Diabetic	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Eplerenone	Eplerenone	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	15	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	15	suppressed
Rena-Vite Rx	Vit B Comp No.3/Folic/C/Biotin	15	suppressed
Valproic Acid	Valproic Acid	15	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Entecavir	Entecavir	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Prolia	Denosumab	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	12	suppressed
Renal Caps	B Complex W-C No.20/Folic Acid	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error